The Group has invested heavily, especially in R&D, to offer the right products to meet the needs of professionals, notably in vaccines, reproduction and anti-infectives.
The biological range offers vaccines to protect against respiratory diseases like COGLAPIX® (swine pleuropneumonia), HYOGEN® (enzootic pneumonia) and AUPHYL Plus® (Aujeszky’s disease). Next to these there is COGLAPEST® (classical swine fever) and one enteric vaccine, the unique COGLAMUNE® (clostridia). Another important vaccine CEVA VALORATM administered to pig's male as an alternative to surgical castration.
Ceva has completed the range of vaccines with CIRCOVAC® (PCV2), PARVORUVAX® (parvovirus and erysipelas), PARVOVAX® (parvovirus) and PROGRESSIS® (PRRS).
The reproduction range (ALFABEDYL®, ENZAPROST®T) has seen the addition of ALTRESYN® and FERTIPIG® (serum and chorionic gonadotropins). The range is completed by GLEPTOSIL® gleptoferron CEVAMEC® swine parasiticide (ivermectin) and CEVAZURIL® (toltrazuril) against coccidiosis.
At the same time, Ceva has the complete Cevolution anti-infective range of differentiated injectable antibiotics (fast syringeable and easy resuspendable formulations with innovative, practical, shock resistant, light and ergonomic CLAS vials) headed by its leader injectable amoxicillin VETRIMOXIN®LA and followed by FLORKEM®, MARBOX™ or CEVAXEL®RTU among others.
The pharma range is completed by non-steroidal anti-inflammatory drugs (NSAID) in injectable forms: GENIXINE® and KETOFEN® 10%.
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the Ceva Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.